The Generic and Biosimilar Medicines Association (GBMA) is pleased to announce the completion of its Code of Practice review for 2015. The review indicates that the Code has been effective in formalising the high standards of conduct adhered to by its Members.
Pursuant to section 14 of the Code, the Code Administration Committee was convened in November 2015 to ensure the successful implementation and ongoing effectiveness of the Code. The Committee prepared its annual report for the GBMA Board. This report is posted below
As set out in section 13 of the Code, an Independent Reviewer has reviewed the Educational Event Reports submitted by Members and conducted spot audits of Members’ marketing and promotional material to determine compliance with the Code. The Independent Reviewer concluded that there was nothing to indicate any level of non-compliance by Members. The Independent Reviewer’s report is posted below.